PONSEGROMAB
UNII GXA6PF0254

Substance Identification & Data

This profile provides standardized clinical and technical data for Ponsegromab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GXA6PF0254.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2368950-15-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

GXA6PF0254

CAS Registry Number

2368950-15-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PONSEGROMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175944

National Cancer Institute reference terminology for clinical and research data.

INN ID

11605

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-82

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ponsegromab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PONSEGROMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (237-ALANINE,238-ALANINE,240-ALANINE), ANTI-(HUMAN GROWTH DIFFERENTIATION FACTOR 15) (HUMAN-MUS MUSCULUS MONOCLONAL PF-06946860 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PF-06946860 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS GROWTH/DIFFERENTIATION FACTOR 15 (NSAID-ACTIVATED GENE 1 PROTEIN, PLACENTAL BONE MORPHOGENIC PROTEIN)); HUMAN-MUS MUSCULUS MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN, HUMAN-MUS MUSCULUS (1-449) (VH (HOMO SAPIENS IGHV1-69*01 (94%) (IGHD)-IGHJ1*01) / MUS MUSCULUS IGHV1-4*01 (70%) (IGHD)-IGHJ4*01) (87%)) (8.8.13) (1-120)-IGHG1*03 (CH1(R97>K(227)), CH2(L4>A(237),L5>A(238),G7>A(240)), CH3(K107>DEL(450))) (121-449)) (223-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN, HUMAN-MUS MUSCULUS (1'-214') (HOMO SAPIENS IGKV3-11*02 (92%) IGKJ1*01 / MUS MUSCULUS IGKV18-36*01 (77%) IGKJ1*01 (83%)) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (229-229'':232-232'')-BISDISULFIDE

PONSEGROMAB [INN]

PONSEGROMAB [USAN]

PONSEGROMAB [WHO-DD]